Grab stock edges higher in premarket as lidar deal and fintech rollout land ahead of earnings

Grab stock edges higher in premarket as lidar deal and fintech rollout land ahead of earnings

NEW YORK, Feb 6, 2026, 08:27 EST — Premarket

  • Grab shares rose around 0.7% in premarket, bouncing back from a near 1% decline in the previous session
  • Hesai appointed Grab as its exclusive lidar sensor distributor in Southeast Asia
  • Grab Finance announced it has rolled out automated credit decisioning via FICO’s platform in six countries

Grab Holdings Ltd shares edged up roughly 0.7% to $4.18 in premarket trading Friday. On Thursday, the stock slipped around 1% to close at $4.15. 1

Investors are weighing new partnerships in two key areas Grab has been focusing on: autonomous technology and financial services. These sectors lie beyond its main ride-hailing and food delivery operations, yet they have the potential to impact both costs and growth prospects.

For Grab, even minor updates carry weight as it gears up to report earnings next week. The focus won’t be on flashy new launches but on the tough realities of margins, incentives, and what it takes to keep users spending.

On Feb. 4, Hesai Technology named Grab its exclusive distributor for lidar products in Southeast Asia. Grab will take charge of sales, customer support, and marketing. Lidar, short for light detection and ranging, uses laser light to gauge distances and help vehicles or robots navigate their environment. Grab CEO Anthony Tan called the partnership crucial for giving robotics the “essential ‘eyes’” to see and move safely. Hesai CEO David Li emphasized lidar as a key technology behind autonomous perception. 2

On the same day, Grab Finance announced it deployed 22 automated credit decision workflows across six Southeast Asian countries in less than eight months, powered by FICO’s platform. The move boosted credit-offer eligibility by nearly 50%. Andre Tan, regional head of lending risk platforms at Grab Finance, said the technology enables “contextual, real-time credit offers” directly within the Grab app. 3

Growth stocks have faced a rough patch, with the Nasdaq dropping roughly 1.6% on Thursday amid a wider selloff in U.S. markets, tech shares taking the brunt of the decline. 4

Neither deal offers Grab shareholders a clear dollar amount to work with just yet. Revenue from distribution agreements tends to roll in slowly, and lending growth raises a tougher issue down the line — credit quality — particularly if consumers and small merchants start to struggle.

Grab has been leveraging the pre-results period to promote new offerings built on its network and app data. Investors, however, keep circling back to one question: can it scale without costs climbing faster than sales?

Grab announced it will publish unaudited Q4 and full-year 2025 results after U.S. markets close on Feb. 11. Management is set to discuss the numbers during a 7:00 p.m. Eastern conference call the same day. 5

The next clear catalyst is that call. Traders will be keyed in on any specifics about how fast these newer initiatives can shift from “strategic” to tangible — and what impact they might have on margins along the way.

Stock Market Today

  • Bitcoin's rough week, Amazon's drop, TrumpRx launch and market updates
    February 6, 2026, 10:21 AM EST. U.S. shares of Stellantis plunged over 25% following a $26 billion business overhaul charge. Bitcoin and tech stocks faced declines amid concerns over AI spending impacts on the software sector. Amazon shares fell 8% despite beating revenue forecasts, as investors questioned its planned $200 billion capital expenditure mainly on data centers. Big Tech firms, including Alphabet and Meta, lost over $1 trillion in market value this week amid rising spending worries. Meanwhile, former President Trump launched the TrumpRx platform to help reduce U.S. prescription drug costs by directing consumers to discounted sources, amid growing focus on high drug prices compared to other developed countries.
Amazon stock slides premarket as $200B AI spending plan reopens Wall Street’s capex fight
Previous Story

Amazon stock slides premarket as $200B AI spending plan reopens Wall Street’s capex fight

Hims & Hers (HIMS) stock slides premarket as FDA targets “copycat drugs” over $49 Wegovy pill
Next Story

Hims & Hers (HIMS) stock slides premarket as FDA targets “copycat drugs” over $49 Wegovy pill

Go toTop